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The root of Rubia cordifolia has been used traditionally as a hemostatic agent, while
the aerial part of the plant consisting of leaf and stem is known to exhibit anti-diarrheal
properties and has been widely used as a remedy in many parts of China. As rotavirus
is one of the most commonly associated diarrhea-causing pathogen, this study aims
to investigate the anti-rotaviral effect of R. cordifolia aerial part (RCAP). The cytotoxicity
of RCAP toward MA-104 cells was evaluated using the WST-8 assay. Colloidal gold
method and real time polymerase chain reaction (qPCR) assay were used to confirm
the findings of the antiviral assay. Then, 4′,6-diamidino-2-phenylindole (DAPI) staining
method was subsequently used to investigate the mode of death among the cells.
And the representative components of aqueous extract were isolated and identified.
It was shown that both the viability of MA-104 cells and the viral load were reduced
with increasing concentration of the extract. DAPI staining showed that virus-induced
apoptosis was the cause of the low cell viability and viral load, an effect which was
accelerated with incubation in the aqueous herbal extract. The major compounds
postulated to exhibit this activity were isolated from the aqueous herbal extract and
identified to be compounds Xanthopurpurin and Vanillic Acid. This study showed that
RCAP extract effectively inhibited rotavirus multiplication by promoting virus-induced
apoptosis in MA-104 cells.
Keywords: Rubia cordifolia, aerial part, rotavirus, antiviral activity, apoptosis, diarrhea
INTRODUCTION
Rotavirus, pathogenic to both man and animals, is a non-enveloped virus with a triple-layered
double capsid and 11 segments of double-stranded Ribonucleic acid (RNA; Goncalves et al., 2005).
It is the most common diarrhea-causing pathogen in children world-wide (Parashar et al., 1998;
Cecilio et al., 2012). Every year, two million children are hospitalized, and 800,000 deaths occur due
to rotavirus-associated diseases (Atherly et al., 2009; Mameli et al., 2012). The virus is transmitted
via the oral-fecal route and the disease is a consequence of viral replication inside the small intestine
(Davidson et al., 1975; Tallett et al., 1977). Clinical manifestations of rotavirus gastroenteritis are
typically fever, vomiting, abdominal pain, diarrhea and dehydration (Walker-Smith, 1978; Cecilio
et al., 2012; Paul et al., 2014).
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Progress has been made in recent years in the discovery of
anti-viral drugs such as chemicals, probiotics, immunoglobulins
and natural products (Heaton and Ciarlet, 2007; Teran et al.,
2009; Grandy et al., 2010; Knipping et al., 2012). Some
commercially available chemical drugs have since been examined
in clinical trials to have shown promising anti-rotaviral activities
(Gu et al., 2000). Ribavirin was reported to exert its anti-
rotavirus activity by inhibiting guanosine 5′-monophosphate
biosynthesis (Schoub and Prozesky, 1977; Smee et al., 1982).
Cimetidine and famotidine showed broad spectrum antiviral
activities (Kabuta et al., 1989; Bourinbaiar and Fruhstorfer,
1996) and have been proven to be effective in rotavirus
gastroenteritis (Li et al., 1995). Nitazoxanide was also reported
to shorten the duration of diarrhea and hospitalization caused
by rotavirus (Rossignol et al., 2006; Teran et al., 2009). However,
their severe side effects were noted in clinical trials (Kim
et al., 2012). Probiotics have also been explored to treat
diarrhea caused by rotavirus. However, it remains unclear
which type of probiotics are useful and the appropriate dose
for children remained questionable (Kolader et al., 2013). In
addition, high costs of probiotics ranging from US$10 to US$15
for a 5-day treatment deters them from being used in the
treatment of rotavirus-induced diarrhea, especially in developing
countries. Thus, the replacement of fluids and electrolytes
remains the gold standard for the management of rotaviral
gastroenteritis (Fischer Walker et al., 2011). Although fluid
and electrolyte replacement may be beneficial to patients who
are malnourished and with persistent diarrhea, this approach
may not be fully effective in alleviating the rotavirus-induced
diarrhea in children. The efficacy of an agent against the
rotavirus and a good side effect profile are therefore essential
considerations. To this end, antiviral agents from natural
sources served as promising candidates for new drug discovery
(Kwon et al., 2010; Chingwaru et al., 2011; Tam and Roner,
2011).
Rubia cordifolia (Qiancao in Chinese), also known as Madder,
is a perennial climber that is widely distributed in China and
India (Li et al., 2009; Do et al., 2013). In Traditional Chinese
Medicine, the extract of R. cordifolia root has blood coagulating
properties. Recently, several studies have reported a variety of
medicinal properties including anti-tumor, anti-inflammatory,
antimicrobial and apoptotic effects from its root (Zhou et al.,
2012; Do et al., 2013; Kaur et al., 2014). The aerial part of
R. cordifolia, referred to as R. cordifolia aerial part (RCAP),
consisting of leaf and stem is widely used in Hanzhong city
of Shaanxi Province, China, for the treatment of diarrhea in
children. In light of this, we aim to investigate the biological
mechanism underlying the anti-diarrheal effect of RCAP by
studying their antiviral property, particularly the RCAP aqueous
extract against rotavirus.
In this study, we first evaluated the cytotoxicity of the aqueous
extract of RCAP on healthy MA-104 cell line. The extract was
then incubated with virus-infected cells to assess its anti-viral
efficacy. The effects of the rotavirus-induced apoptosis were
studied in the presence of the extract. To our knowledge, this is
the first study aimed to elucidate the anti-rotaviral activity of the
RCAP.
MATERIALS AND METHODS
Preparation of Extract
RCAP was collected from Hanzhong city of Shaanxi Province. All
the plant materials were air dried, powdered and deposited at the
Department of Pharmacy, Tongji Hospital. Hot water extract of
the plant was prepared according to the procedures as described.
The plant (1 kg) was boiled in 1 L of distilled water for 1 h. The
aqueous solution was collected and the residual was extracted
again with another 1 L of distilled water. This step was repeated,
until the extract became transparent. All of the aqueous extracts
were combined, filtered through gauze, concentrated under low
pressure and lyophilized. The lyophilized powder was dissolved
in sterile distilled water.
Cell and Virus Culture
The rhesus monkey kidney cell line MA-104 and human
rotavirus G9 were obtained from Dr. Jihong Yang. The MA-
104 cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% v/v fetal bovine serum (FBS;
Hyclone Laboratories Inc., USA) and 1% v/v of 10,000 unit/mL
penicillin and 10,000µg/mL streptomycin. The cell cultures were
maintained at 37◦C in a humidified 5% CO2 atmosphere under
aseptic condition. Rotavirus was activated with 15 µg/mL trypsin
for 30 min at 37◦C and propagated in MA-104 cells monolayer
in the presence of 5 µg/mL trypsin. The virus titer was estimated
from cytopathogenicity by limit-dilution method and expressed
as 50% tissue culture infectious dose (TCID50/mL) by the Reed
and Muench (1938) statistical method.
Determination of the Maximum
Non-toxic Concentration
The cytotoxicity of the tested extract was evaluated using WST-8
assay (Tominaga et al., 1999). MA-104 cells (5000 cells/well)
were grown in 96-well plate for 24 h. Different concentrations
of aqueous extract were applied to culture wells in quadruplicate
(1.95, 3.91, 7.81, 15.63, 31.25, 62.5, 125, 250, 500, 1000 mg/mL).
After incubation at 37◦C, 5% CO2 for 48 h, 10 µL of WST-8
solution was added to each well. Plates were then incubated at
37◦C for 2 h. A microplate reader was used to test the absorbance
of each well at 450 nm. The control for this assay was monolayer
MA-104 cells incubated only with DMEM. Results were
estimated by regression analysis. Cell viability was calculated as
ODex / ODcon × 100%. ODex indicates the absorbance of
extract treated group. ODcon indicates the absorbance of the
control cells without the extract. The highest concentration of the
extract which showed no significant statistical difference from the
controls in cell viability was deemed as the maximum non-toxic
concentration (MNTC).
Antiviral Assay
Antiviral assays used in this study have been described by Barnard
et al. (1997). In the mixed treatment assay: Extract diluted with
DMEM containing 5 µg/mL trypsin was mixed with rotavirus
at various concentrations (0.12, 0.24, 0.49, 0.98, 1.95, 3.91, 7.81,
15.63, 31.25, 62.5 mg/mL), which were then incubated at 37◦C
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for 2 h. The mixtures were inoculated in quadruplicate onto
near confluent MA-104 cells monolayer in two 96-well plates,
each well containing 100TCID50 of the rotavirus. The cells
were incubated at 37◦C with 5% CO2 atmosphere for 48 h
and observed with an inverted microscope. Then, WST-8 assay
was done in one 96-well plate as previously described and
the supernatant of each group in the other plate was gathered
and tested with the rotavirus detection kit (Wantai BioPharm,
Beijing, China) at 4◦C. Cell viability was calculated as ODrv /
ODcon × 100%. ODrv indicated the absorbance of rotavirus
infected group with or without RCAP extract. ODcon indicates
the absorbance of non-infected cells without RCAP extract
(control).
In the post treatment assay: 100TCID50 of the rotavirus was
inoculated onto the near confluent MA-104 cells monolayer for
1 h. Extract of various concentrations (0.12, 0.24, 0.49, 0.98,
1.95, 3.91, 7.81, 15.63, 31.25, 62.5 mg/mL) diluted with DMEM
containing 5µg/mL trypsin were added in quadruplicate. The cell
viability was tested and the content of each group was gathered as
described before.
RNA Extraction
The contents gathered from the antiviral assay were used in
the extraction of the rotavirus RNA. RNAs were extracted by
a TRI Reagent method (Kim et al., 2014). For TRI Reagent
extraction, 500 µL of each sample was incubated with 500 µL
TRI reagent (Sigma-Aldrich Chemical Company) for 10 min at
room temperature, followed by supplementation with 100 µL
chloroform. After vigorous mixing for 10 s and centrifugation at
13000 rpm for 15 min at 4◦C, the upper layer was transferred into
a fresh tube. An aliquot of 400 µL iso-propanol was added and
the resulting mixture incubated for 10 min at room temperature,
followed by centrifugation at 13000 rpm for 10 min. After
centrifugation the supernatant was discarded, and the remaining
was washed with 1 mL 75% ethanol and air-dried for 10 min. RNA
was dissolved in 20 µL RNase-free water.
Quantification of Rotavirus by Real Time
Polymerase Chain Reaction (qPCR)
Assay
(i) Complementary DNA (cDNA) synthesis – the cDNA synthesis
was conducted in a 25 µL reaction container using M-MLV
Reverse Transcriptase. Firstly, 4 µL of extracted viral RNA, 1 µL
of each primer and 11 µL RNase-free water, were incubated at
70◦C for 10 min and then quickly chilled on ice for 5 min. After
this, 5× reaction buffer was added, 1µL of each deoxynucleotide
(dNTP), 1 µL RNasin Ribonuclease inhibitor and 1 µL M-MLV
Reverse Transcriptase. The reaction was incubated for 60 min at
37◦C, 5 min at 70◦C. The cDNAs were maintained at 80◦C until
required. (ii) Primers – the primers used for rotavirus protein
(VP6) region amplification were: Rota A (forward primer): 5′-
GACGGVGCRACTACATGGT-3′ (V = A/C R = A/G) and
Rota A (reverse primer): 5′-GTCCAATTCATNCCTGGTGG-3′
(N = A/G), which amplify a 379-bp product (Kang et al., 2004).
They were synthesized commercially (Takara Bio Inc., China).
(iii) The qPCR assay was performed on a CFX96 TouchTM Real-
Time PCR Detection System (Bio-Rad, USA) using SYBR premix
Ex Taq. The assay was carried out in a total volume of 25 µL
reaction mixture containing 12.5 µL SYBR premix Ex Taq master
mix, 2 µL of cDNA, 1 µL of each primer and 8.5 µL RNase-
free water. The optimized cycling conditions were as follow:
initial denaturation at 95◦C for 10 s, followed by 40 cycles of
denaturation at 95◦C for 10 s, primer annealing and extension
at 56◦C for 30 s. Fluorescence signals were recorded at the end
of each cycle. A melt curve analysis was measured following
amplification to confirm the specificity of the amplified products.
Melting curve analysis consisted of 65◦C for 5 s, and followed
by increase in temperature to 95◦C for 5 s with continuous
fluorescence reading. RNase-free water, 5 × reaction buffer,
dNTP, RNasin Ribonuclease inhibitor, SYBR premix Ex Taq used
in qPCR were all obtained from Takara (Takara Bio Inc., China).
4′,6-diamidino-2-phenylindole (DAPI)
Staining Assay
Cell nuclear morphology was evaluated by fluorescence
microscopy following DAPI (Roche Diagnostics GmbH.,
Germany) staining. After gathering the contents from the
antiviral assay, the monolayer consisting of MA-104 cells
was washed once with DAPI-methanol (working solution,
1 µg/mL). Then, the cells were covered with DAPI-methanol
and incubated for 15 min at 37◦C. The staining solution was
discarded after 15 min of incubation and the sample was washed
once with methanol. The 96-well plates were examined under a
fluorescence microscope (Nikon Eclipse Ti, Nikon Instruments
Inc., USA). Different concentrations of aqueous extract were
added to MA-104 cells for 48 h in another 96-well plate without
incubation with rotavirus. The cells were observed under an
inverted microscope. Then, DAPI staining was performed after
discarding the supernatant to observe the effects of the extract on
the cells, before and after treatment with RCAP extract.
Isolation and Identification of the
Representative Components
The aqueous extract of RCAP was partitioned with ethyl acetate,
CHCl3 and n-butanol, consecutively. Comparing the volumes
of each fraction, ethyl acetate fraction was chromatographed on
silica gel column (Qing-dao Marine Chemical Inc., China). The
column was washed and eluted, then the eluates were separated
and confirmed by thin-layer chromatography (Yantai Chemical
Industry Research Institute, China). For further purification of
active components, semi-preparative HPLC was carried out on
a Dionex quaternary system with a diode array detector at a
flow rate of 2.5 mL/min using a reversed-phased C18 column
(5 µm, 10 × 250 mm, YMC-pack ODS-A). The representative
active compounds isolated were identified by analyzing them on
a Bruker AM-400 spectrometer (Bruker Corporation, USA).
Statistical Analysis
Study results were analyzed using SPSS software (ver. 18.0; SPSS,
Inc., USA). Results were presented as mean± standard deviation
(SD). One-Way ANOVA test was used to calculate differences.
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Statistical significance was indicated at p < 0.05. Curves of real-
time qPCR were analyzed using CFX Manager Software (ver. 3.0;
Bio-Rad, Inc., USA).
RESULTS
Cytotoxicity of the RCAP Extract in
MA-104 Cells
It was shown that there was no significant difference between
the control and the extract treated group in the aspect of cell
viability, for RCAP concentrations up to 62.5 mg/mL (Figure 1).
Based on this result, the concentrations of extract that exhibited
cytotoxicity were excluded from the subsequent antiviral assay
and 10 concentrations (0.12, 0.24, 0.49, 0.98, 1.95, 3.91, 7.81,
15.63, 31.25, 62.5 mg/mL) were used.
Antiviral Activity of RCAP Extract
In the mixed treatment assay, after various concentrations of
extract and rotavirus were mixed and incubated, the mixtures
were inoculated onto the confluent monolayer cells. The
morphological changes of the virus infected or non-infected
RCAP extract treated MA-104 cells were observed with light
microscopy, after the cells in the virus control group (VCG,
cells were only inoculated with virus) showed viral cytopathic
effect (CPE). It was found that these affected cells increased
with an increasing concentration of the extract (Figure 2B),
while the morphology of non-infected cells treated with RCAP
extract remained consistent regardless of the RCAP extract
concentration (Figure 2A). This finding was consistent with
the cell viability assay (Figure 3A). In the post-treatment assay,
a similar situation was observed. As the extract concentration
increased, more affected cells can be observed. There was indeed
a negative relationship between cell viability and RCAP extract
concentration (Figure 3A).
To study the virus quantitatively, a rotavirus detection kit was
used on the supernatant isolated from each group. The color of
the test line, indicative of the viral load, showed a reduction in
intensity with increasing concentration of the extract. The color
of the test line became undetectable when the extract reached
a concentration of 15.63 mg/mL (Figure 3B). These results
showed that the amounts of rotavirus decreased with increasing
concentration of extract and could not be detected at higher
concentrations of extract.
To study the virus qualitatively, the SYBR Green-based qPCR
assay was used. The contents (virus, the extract and cellular
debris) collected from 10 different tested groups in mix treatment
assay were examined. After cDNAs were prepared, the samples
were quantified with ultraviolet spectroscopy. Ct values can be
used as a quantitative measurement of the input target number
which reflects the viral load in antiviral assay, and there was
a negative relationship between Ct value and the viral load.
The quantities of rotavirus were compared across treated groups
by using their Ct values. It was found the viral load was
reduced as the concentration of the extract increased (Figure 4A).
A similar trend was observed in post treatment assay as well
(Figure 4B).
These results indicated that the extract exerted potential anti-
rotavirus effect, not by affecting the rotavirus directly, but by
acting on the infected MA-104 cells. The order of adding the
rotavirus to the cells did not undermine the anti-viral effect of
the extract. The antiviral effect was more pronounced when the
FIGURE 1 | Cytotoxicity of RCAP extract in MA-104 cells. The non-toxic groups were determined by comparing the cell viability. Cell viability was calculated as
ODex / ODcon × 100%, and ODcon = 1.74 ± 0.06. Data are represented as mean ± S.D. n = 11. ∗p < 0.05 vs mock; ∗∗p < 0.01 vs mock by one-way ANOVA test,
post hoc Tukey test.
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FIGURE 2 | Morphological observation of MA-104 cells in antiviral assay. (A) Non-infected cells incubated with RCAP extract; (B) Rotavirus-infected cells
treated with RCAP extract. Morphological changes were characterized by rounding and enlargement of the cells and by detachment of the cells from the substrate.
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FIGURE 3 | Effect of RCAP on cell viability and viral load in antiviral assay. (A) Cell viability of each group in mixed and post treatment assay. Cell viability was
calculated as ODrv / ODcon × 100%, ODcon of mixed treatment assay was 1.11 ± 0.03, ODcon of post treatment assay was 1.18 ± 0.03; (B) Detection of rotavirus
in each group using the colloidal gold method. Control line indicates valid testing; test line indicates presence of rotaviruses.
FIGURE 4 | Quantification of rotavirus by real time qPCR assay (A) Viral load in each group of mixed treatment assay; (B) Viral load in each group of
post treatment assay. Ct values can be used as a quantitative measurement of the input target number which reflects the viral load in antiviral assay, and there was
a negative relationship between Ct value and the viral load.
Frontiers in Pharmacology | www.frontiersin.org 6 September 2016 | Volume 7 | Article 308
fphar-07-00308 September 9, 2016 Time: 13:6 # 7
Sun et al. Rubia cordifolia Extract Inhibits Rotavirus
virus was added to the cells prior to adding the extract, i.e., the
post treatment assay.
Effect of RCAP Extract on Infected
MA-104 Cells
In our study, both the cell and viral viability decreased
with increasing concentrations of the herbal extract. This
may suggest that the death of MA-104 cells was not caused
by the viral infection, as the amounts of viruses did not
increase significantly with decreasing cell viability (Ward et al.,
1984). Programmed cell death, also known as apoptosis, is
defined as a physiological cell suicide process alternative
to necrosis. Apoptosis can be differentiated from necrosis
by their characteristic nuclear fluorescence when excited
under fluorescence microscope. In our study, DAPI staining
revealed apoptosis in MA-104 cells caused by rotavirus.
The apoptosis was shown to be accelerated by the RCAP
extract. The morphological changes associated with apoptosis
such as chromatin condensation, nuclear fragmentation, and
margination of nucleus were evident in MA-104 cells. Moreover,
it was shown that the amounts of apoptotic cells increased
with increasing concentrations of the extract (Figure 5B). The
cells in the viral control group exhibited signs of apoptosis
induced by rotavirus, though not as significant compared
to the treatment group. However, the extract itself did not
result in any apoptosis in the cells (Figure 5A). The results
indicated that the elimination of rotavirus may be due to the
apoptosis of virus-infected MA-104 cells accelerated by the herbal
extract.
FIGURE 5 | Characteristic nuclear fluorescence of MA-104 cells with DAPI staining. (A) Non-infected cells being treated with different concentrations of
RCAP extract; (B) Rotavirus-infected cells being treated with different concentrations of RCAP extract. Red arrows correspond to nuclear fragmentation of apoptotic
cells.
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Measurement of the Representative
Components in RCAP Extract
There were three compounds isolated and identified from
the ethyl acetate fraction of RCAP aqueous extract, which
were 1,3-dihydroxy-9,10-anthracenedione (xanthopurpurin;
Figure 6A), 4-hydroxy-3-methoxybenzoic acid (vanillic acid;
Figure 6B) and 1-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydro-7-
hydroxy-6-methoxy-2,3-naphthalenedi methanol (isotaxiresinol;
Figure 6C). The extraction and separation processes, the
NMR spectrums of these three compounds were shown in the
Supplementary Material. Among them, xanthopurpurin and
vanillic acid were considered to be responsible for the anti-viral
effect observed with the RCAP aqueous extract.
DISCUSSION AND CONCLUSION
R. cordifolia is widely used in China owing to the hemostatic effect
of its roots (Zhang et al., 2005). Moreover, the water decoction of
RCAP and a commercial medicine, namely, Erxieting R©, obtained
from RCAP, have long been used in clinical practice to treat
diarrhea in children (Cui et al., 2005). Rotaviruses are the
single most important cause of severe diarrhea (Fields et al.,
2007). Therefore, we hypothesized that the anti-diarrheal effect
of RCAP was to inhibit the replication of rotavirus. Based on
the clinical applications of RCAP, we further hypothesized that
the effective constituent exists in the aqueous extract of RCAP.
Based on the hypotheses, we adopted the water decocting method
to obtain the aqueous extract and studied its activity against
rotavirus.
It was observed, for concentrations below 62.5 mg/mL, RCAP
extract by itself did not exhibit any cytotoxicity. However, the
cell viability decreased with increased extract concentration
when the viruses were present. Initially, it was postulated that
RCAP acted on rotavirus directly and promoted its proliferation
because increased amounts of virus can reduce host cell viability.
However, this was not the case observed in this study as the viral
load did not increase with increasing extract concentration. This
result motivated us to investigate further the mechanism of how
RCAP extract induced cell death in rotaviral-infected cells.
Apoptosis is an active mode of cell death exhibiting a series
of morphological and biochemical changes (Koyama et al., 1998;
Galluzzi et al., 2008). Apoptosis can be induced by extrinsic
signals, such as cytokines, or intrinsic stimuli that impinge on the
integrity of mitochondria (Upton and Chan, 2014). Many animal
viruses are known to induce apoptosis in infected cells, such as
HIV, HBV and rotavirus (Basanez and Zimmerberg, 2001; Zhang
et al., 2005).
Rotavirus has been reported to induce apoptosis in polarized
epithelial cell lines, such as Caco-2 cells and HT-29 cells (Superti
et al., 1996; Chaibi et al., 2005). In our study, we also observed
apoptosis in MA-104 cells when incubated with 100TCID50
of the rotavirus for 48 h (Figure 5B). The results showed
that not all the cells exhibited the characteristics of apoptosis.
This is probably due to the heterogeneity in the stages of
virus multiplication in each cell and that the rotavirus-induced
apoptosis is time-dependent (Chaibi et al., 2005). However, when
the extract was added, the amounts of apoptotic cells increased
dramatically.
Although studies of apoptosis on in vitro viral replication
revealed that host cell apoptotic responses can provide protection
against viral infection (Everett and McFadden, 1999), rotavirus
induced apoptosis by itself does not have an essential role
in the host defense mechanism against viral infections. The
multiplication of viruses may be slightly suppressed in the
apoptotic cells, but that apoptosis in virus-infected cells cannot
bring about the abortion of progeny virus formation. Rotavirus
can grow significantly in cells undergoing apoptosis and is
able to escape this host defense by completing multiplication
before the onset of apoptosis. However, if the apoptotic process
can be accelerated, then it can become a significant defensing
mechanism against viruses.
In our study, we showed that below 62.5 mg/mL, the extract
itself did not induce apoptosis (Figure 5A). On the other
hand, the extract, which was administered together with viruses,
accelerated apoptosis in a dose-dependent manner. From these
results we concluded that, the extract may potentially accelerate
the induction of rotavirus-induced apoptosis in MA-104 cells,
with concomitant reduction of progeny virus production. The
subsequent premature lysis by apoptosis of the rotavirus-infected
FIGURE 6 | Structures of components isolated and identified from the ethyl acetate fraction of RCAP aqueous extraction. (A) 1,3-dihydroxy-9,
10-anthracenedione (xanthopurpurin); (B) 4-hydroxy-3-methoxybenzoic acid (vanillic acid); (C) 1-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydro-7-hydroxy-6-methoxy-2,
3-naphthalenedimethanol (isotaxiresinol).
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cells can have a significant effect on the suppression of virus
multiplication.
Considering the ethyl acetate fraction of RCAP water
extraction had the largest volume of fractions with different
polarity, we isolated and identified the representative
components from this fraction. Xanthopurpurin is one of 10
dihydroxyanthraquinone isomers. Its molecular structure is
similar to other anthraquinones occuring in madder, such as
alizarin and purpurin (Derksen et al., 2002). Along with alizarin,
purpurin, and other anthraquinones like mollugin, these major
phyto-constituents reported in this plant have the function
of activating caspase-3, a typical marker for cell undergoing
apoptosis (Kim et al., 2009; Fotia et al., 2012; Tiwari et al.,
2012; Tsang et al., 2013). Vanillic acid can induce apoptosis
in HT-29 cell (Ho et al., 2009), and was deemed effective in
the regulation of chronic intestinal inflammation by reducing
the plasma level of interleukin 6 (IL-6; Kim et al., 2010). To
control the immune response caused by pro-inflammatory
cytokines (such as IL-1 and IL-6) during rotaviral infections
is one of the major research directions of treating virus
gastroenteritis (Azevedo et al., 2006). Thus, xanthopurpurin
and vanillic acid may be regarded as potential anti-rotaviral
reagents in the aqueous extract of RCAP, which requires further
study.
This study has therefore demonstrated that the promotion
of rotavirus-induced apoptosis is the main contributing
mechanism of RCAP aqueous extract’s anti-viral property against
rotavirus.
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